Physician profile
Marjorie Christopher
NPI 1790261535
$4,699.40
in general payments reported to CMS, 2019-2025
42 companies · $1,178 in 2025
The $1,178 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.67 · 2022: $928 · 2023: $1,146 · 2024: $1,366 · 2025: $1,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,690.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $635.76 | 2022-2025 | Evenity, Prolia, Repatha |
| Lilly USA, LLC | $612.01 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $595.98 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $403.33 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $371.43 | 2023-2025 | |
| Abbvie INC. | $324.68 | 2021-2025 | |
| Glaxosmithkline, LLC. | $206.97 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.48 | 2022-2025 | Jardiance |
| Grifols USA, LLC | $135.94 | 2022-2024 | Prolastin-C Liquid |
| Shield Therapeutics INC | $98.54 | 2024-2025 | |
| Abbott Laboratories | $83.47 | 2022-2024 | Freestyle Libre |
| Phathom Pharmaceuticals, INC. | $71.58 | 2024-2025 | Voquezna |
| Dexcom, INC. | $69.34 | 2022-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Halozyme INC | $66.55 | 2023 | |
| Amneal Pharmaceuticals LLC | $64.02 | 2024 | Unithroid |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Christopher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.